Last reviewed: July 17, 2026
Last updated: July 17, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Tirzepatide is a once-weekly injectable medication that activates both GLP-1 and GIP receptors, producing greater appetite suppression than single-receptor agents. Learning proper injection technique ensures consistent medication delivery and reduces injection-site discomfort. This guide walks through every step of safe home administration from PlexusDx.
Preparing Your Tirzepatide Injection
Before injecting, gather your supplies: the tirzepatide pen or vial, a new sterile needle, alcohol swabs, and a sharps container for safe needle disposal. Check the medication appearance—it should be clear and colorless. Never use tirzepatide if it appears cloudy, discolored, or contains particles. Verify the expiration date on your PlexusDx shipment and store unused pens in the refrigerator between 36–46°F (2–8°C) until needed.
Allow the pen to reach room temperature for 15–30 minutes before injection. Cold medication can increase injection discomfort and may affect absorption. Wash your hands thoroughly with soap and water, then clean the injection site with an alcohol swab and let it air-dry completely. Never inject through clothing or into areas with active skin infections, scars, or bruises. Rotating injection sites weekly reduces tissue irritation and lipodystrophy risk.
Step-by-Step Tirzepatide Injection Technique
Select your injection site: the abdomen (at least two inches from the navel), upper thigh, or back of the upper arm. Pinch the skin with one hand to create a small fold. Using your other hand, insert the needle at a 45–90 degree angle in one smooth, quick motion. The angle depends on body composition—thinner individuals may use 45 degrees, while those with more subcutaneous tissue can use 90 degrees. Once the needle is fully inserted, depress the plunger slowly and steadily until the dose is delivered.
Hold the needle in place for three seconds after injecting to ensure all medication enters the tissue. Withdraw the needle at the same angle of insertion and apply gentle pressure with a dry cotton ball or gauze if bleeding occurs. Never recap the needle. Dispose of the used needle immediately in a sharps container, never in regular trash. Some patients experience a small amount of bleeding or mild bruising—this is normal and not cause for concern.
Managing Injection Site Reactions and Discomfort
Mild redness, warmth, or bruising at the injection site typically resolves within 24 hours. Applying ice for 10 minutes before injection can reduce discomfort and minimize bruising in sensitive individuals. After injection, a warm compress may relieve any lingering tenderness. If you develop severe pain, persistent redness lasting more than three days, signs of infection (warmth, pus, increasing swelling), or an allergic reaction (hives, difficulty breathing), contact your healthcare provider immediately.
Rotating injection sites prevents lipohypertrophy (thickened fat deposits) and lipodystrophy (loss of fat at injection sites), both of which can interfere with consistent medication absorption. PlexusDx recommends maintaining a simple rotation chart—for example, alternating between left and right abdomen each week, then moving to the thigh the following week. This systematic approach ensures even distribution of injections across available tissue.
Storage, Handling, and Dose Adjustments
Unopened tirzepatide pens must be stored in the refrigerator between 36–46°F (2–8°C) and kept away from direct light and heat. Once you begin using a pen, it can be stored at room temperature (up to 77°F or 25°C) for up to 28 days. Do not freeze tirzepatide or expose it to extreme temperatures, as this damages the medication. When traveling, use an insulated cooler bag with ice packs to maintain the proper temperature range, and never leave medication in a hot car.
Your dose may increase over time—PlexusDx starts most patients at a low dose and titrates upward weekly or bi-weekly based on tolerability and clinical response. Common starting doses for tirzepatide range from 2.5 mg to 5 mg weekly, with increases up to 15 mg depending on individual factors including genetic predispositions identified through the Precision Peptide Genetic Test. Your PlexusDx provider will guide all dose adjustments. Importantly, your dose may need to go up, but your price won't—flat monthly pricing remains consistent across all dose levels at $249–$289 per month depending on your commitment tier.
When to Seek Help From Your PlexusDx Provider
Contact your PlexusDx healthcare team if you experience severe nausea, vomiting, or abdominal pain that interferes with daily life; signs of pancreatitis (severe upper abdominal pain radiating to the back); rapid heartbeat or chest discomfort; or vision changes. Additionally, report any new or worsening joint pain, particularly in the hips and knees, as this may signal medication intolerance. Your provider may adjust your dose, switch to an alternative formulation (oral tirzepatide, for example), or explore complementary options like the Microdose GLP-1 Protocol ($129/mo flat).
If you miss a weekly injection by one or two days, take the dose as soon as you remember. If you miss your dose by more than two days, skip that dose and resume your normal schedule the following week—do not double-dose. PlexusDx patient support is available to answer questions about missed doses, storage concerns, or any uncertainty about injection technique. All medications are dispensed from licensed 503A compounding pharmacies, ensuring quality and safety.
How Your Genetics Relate to GLP-1 Pathways
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection starts at $289/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
What needle size should I use for tirzepatide injections?
PlexusDx supplies or recommends 31-gauge needles (half-inch length), which are fine enough to minimize discomfort while delivering medication reliably into subcutaneous tissue. Always use a new, sterile needle for each injection. Some patients with significant subcutaneous tissue may prefer slightly longer needles—discuss preferences with your PlexusDx provider.
How quickly does tirzepatide work, and when will I see weight loss results?
Most patients begin experiencing reduced appetite within 3–7 days of the first injection. Measurable weight loss typically appears within 2–4 weeks as appetite suppression intensifies. Clinical trials show average weight loss of 15–22% of body weight over 68 weeks at therapeutic doses. Individual results vary based on genetics, lifestyle, and adherence—PlexusDx's Precision Peptide Genetic Test ($99 add-on after first month) identifies GLP1R, GIPR, FTO, and MC4R variants that influence your personal response trajectory.
Does PlexusDx tirzepatide cost change if my dose increases over time?
No. PlexusDx uses flat monthly pricing—your dose may need to go up, but your price won't. Compounded tirzepatide injections start at $289/mo (or $249/mo on the 6-month plan) ($249-$289/mo across commitment tiers), and this price holds regardless of whether you're taking 2.5 mg or 15 mg weekly. HSA and FSA accounts are eligible for payment.
Are PlexusDx compounded tirzepatide injections FDA-approved?
PlexusDx tirzepatide is compounded by licensed 503A pharmacies under U.S. Pharmacopeia (USP) standards for quality and sterility. While the active ingredient tirzepatide is FDA-approved as Mounjaro®, compounded formulations are not FDA-approved but are legally manufactured under the 503A pathway. PlexusDx does not claim compounded medications are FDA-approved; however, all products meet rigorous safety and potency standards.
How do genetic variants affect my tirzepatide response?
No — the Precision Peptide Genetic Test does not predict your response to tirzepatide or any specific medication. It analyzes pathway-level variants (GLP1R (rs6923761), GIPR (rs1800437), FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.
Related Reading
Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Navigating Your Path: Understanding When to Up the Dose of Mounjaro for Effective Weight Management
Is a Headache a Side Effect of Mounjaro? Understanding the Connection